Udg Healthcare PLC Rating Reiterated by N+1 Singer (UDG)
Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating restated by stock analysts at N+1 Singer in a report issued on Tuesday. They currently have a GBX 410 ($7.03) target price on the stock. N+1 Singer’s price target would suggest a potential upside of 15.66% from the stock’s previous close.
Udg Healthcare PLC (LON:UDG) opened at 349.5292 on Tuesday. Udg Healthcare PLC has a 52 week low of GBX 293.30 and a 52 week high of GBX 380.10. The stock has a 50-day moving average of GBX 344.4 and a 200-day moving average of GBX 350.. The company’s market cap is £843.8 million.
A number of other firms have also recently commented on UDG. Analysts at Jefferies Group reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Thursday, June 5th. They now have a GBX 400 ($6.86) price target on the stock. Separately, analysts at Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a research note on Wednesday, May 14th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of GBX 380 ($6.52).
UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in over 20 countries including the United States, the United Kingdom, Ireland, Germany, the Netherlands and Belgium.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.